Journal of Natural Products · 2012 · 41 citations · 31 references
Life SciencesBotanyMedicinal ChemistryCancer PharmacologyDrug DiscoveryPlant BiochemistryMedicinal Plant KnowledgeMedicinal PlantsStructure-activity Relationship AnalysisAnticancer ActivityBioactive Plant CompoundsCancer Cell Line ModelsCardiac GlycosidesFlavonoid GlycosidesMedicinal Plant ResourcesSecondary Metabolites
Phytochemical investigation of the dried biomass of Asclepias syriaca afforded five new compounds (1-5), along with 19 known structures. Overall, the secondary metabolites isolated and identified from this plant showed a wide structural diversity including pentacyclic triterpenes, cardiac glycosides, flavonoid glycosides, lignans, a phenylethanoid, and a glycosylated megastigmane. In addition, the isolates were tested against the cancer breast cell line Hs578T, and those showing IC(50) values lower than 50 μM (1 and 6-9) were further investigated in three additional breast cancer cell lines (MCF-7, T47D, and Sk-Br-3) and the normal breast cell line Hs578Bst.
31
Werner Seebacher, Nebojša Simić, Robert Weis et al. · Magnetic Resonance in Chemistry · 2003 · 465 citations
Adeline J. Hackett, Helene S. Smith, E Springer et al. · JNCI Journal of the National Cancer Institute · 1977 · 300 citations
Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells
Senia Johansson, Petra Lindholm, Joachim Gullbo et al. · Anti-Cancer Drugs · 2001 · 120 citations
Medicine, Oncology, Pharmacology +13